1-3 of 3
O. Beyne-Rauzy, MD
Close
Sort by
Journal Articles

Lenalidomide (LEN) in INT 2 and High Risk MDS with DEL 5q. Interim Results of a Phase II Trial by the GFM.

S. Burcheri, MD, T. Prebet, MD, O. Beyne-Rauzy, MD, R.M. Mbida, MD, N. Hoarau, MD, L. Legros, MD, C. Ravoet, MD, F. Dreyfus, MD, A. Stamatoullas, MD, M.P. Chaury, MD, J. Delaunay, MD, G. Laurent, MD, N. Vey, MD, L. Ades, MD, C. Gardin, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2007) 110 (11): 820.
https://doi.org/10.1182/blood.V110.11.820.820
Published: 2007
Journal Articles

RBC Transfusions and Iron Chelation Therapy in Clinical Practice in MDS: A One Month Survey by the GFM.

Christian Rose, MD, A. Stamatoulas, MD, D. Vassilief, MD, S. Brechignac, MD, O. Beyne-Rauzy, MD, F. Courtois, MD, M. Wemeau, MD, Agnes Guerci, MD, M.P. Chaury, MD, B. Lefs, MD, B. Mahe, MD, L. Roy, MD, Bruno Quesnel, PD, MD, F. Dreyfus, PD, MD, Pierre Fenaux, PD, MD
Journal: Blood
Blood (2006) 108 (11): 2661.
https://doi.org/10.1182/blood.V108.11.2661.2661
Published: 2006
Journal Articles

Clinical Relevance of Cardiac Iron Overload Estimated by MRI T2* in Regularly Transfused Low Risk MDS.

C. Ferte, MD, O. Ernst, MD PhD, O. Beyne-Rauzy, MD, M.P. Chaury, MD, S. Brechignac, MD, M. Brauner, MD PhD, T. Mirault, MD, K. Kanaan, MD, E. Bourgeois, MD, N. Cambier, MD, Bruno Quesnel, MD PhD, Pierre Fenaux, MD PhD, Christian Rose, MD
Journal: Blood
Blood (2006) 108 (11): 2666.
https://doi.org/10.1182/blood.V108.11.2666.2666
Published: 2006